Cancer Clinical Trials:
What the Public Health and Primary Care Provider Need to Know
Originally broadcast December 15, 2011
Yelena Novik, MD, FACP
Assistant Professor; Medical Director-Clinical Trials Office
Department of Medicine (Residency Program)
NYU Cancer Institute
Michael L. Pearl, MD, FACOG, FACS
Professor and Director
Division of Gynecological Oncology
Stony Brook University Hospital
Only 3 – 5% of adult cancer survivors participate in clinical trials; older adults and minorities are even less likely to do so. Increased participation in cancer-related trials benefits society by helping to develop and test the safety of new cancer treatments, and benefits participants who receive high quality cancer care. This Public Health Live webcast will address psychosocial, financial and other barriers to recruitment into cancer clinical trials, highlight the disparities that exist in terms of participation and identify NYS resources and strategies which may help lower barriers and reduce disparities.
After watching this broadcast participants will be able to:
- Understand basic principles relating to cancer clinical trials, including purpose/limitations of Phase I, II and III clinical trials.
- Understand the benefits associated with cancer clinical trials, using lessons learned and best practices gleaned from pediatric cancer clinical trials as a model.
- Understand barriers to participation in clinical trials among adults at-risk for or affected with cancer and identify disparities in clinical trial participation.
- Identify strategies to improve enrollment into cancer clinical trials, across all populations.
This program is offered in partnership with: Cancer Support and Survivorship Initiatives at The New York State Department of Health, Bureau of Chronic Disease Control
Continuing Education Credits
School of Public Health, University at Albany is an approved provider of continuing nursing education by the Massachusetts Association of Registered Nurses, Inc., an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
It has been assigned Provider Code PA# 157N.
Course code PA# 157N-282; 1.0 contact hour.
School of Public Health, University at Albany is accredited by the MSSNY to provide continuing medical education (CME) for physicians. The School designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s).™ Physicians should claim only credit commensurate with the extent of their participation in the activity.
This activity is sponsored by the School of Public Health, University at Albany, SUNY, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for the CHES to receive 1.0 Category 1 CECH in health education.
Continuing education credits are available until December 2014.
The planners and presenters do not have any financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in this activity.
No commercial funding has been accepted for this activity.